No trading action warranted. Monitor future insider transactions and upcoming earnings or clinical trial updates for material developments.
Price Chart
Executive Summary
Mark Voll, newly appointed CFO of RenovoRx, filed an amended Form 3/A to correct his title after previously misstating it as CEO. The filing reflects ownership of 25,000 shares acquired in the open market prior to his appointment. No new share transactions or material financial information were disclosed.
Key Facts
- Mark Voll filed Form 3/A to correct his title from CEO to CFO on the original Form 3 filing.
- He holds 25,000 shares of RNXT common stock, purchased in the open market before becoming CFO.
- No new share purchases, sales, or grants were reported in this amendment.
- The correction was administrative, with no indication of misconduct or financial implications.
Financial Impact
No financial impact — this is a clerical correction with no change in share ownership or capital structure.
Risk Factors
- Minimal reputational risk from initial misfiling, though promptly corrected.
- Low liquidity risk given RNXT's small market cap ($43M), but no direct link to this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3/A Filing (Primary) | 0001493152-26-013082 |
| Document: 0001493152-26-013082-index.html | 0001493152-26-013082 |
| Document: 0001493152-26-013082.txt | 0001493152-26-013082 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $1.27 | awaiting T+60 | — | $1.31 (+3.15%) |
Jul 29, 2026 12w ago | Press Release | $0.8981 $1.27 | ▲ +41.41% | ▲ +36.68% | $1.31 (+45.86%) |
Jul 2, 2026 16w ago | 8-K | $0.9201 $1.68 | ▼ −82.59% | ▼ −79.58% | $1.31 (−42.38%) |
May 26, 2026 22w ago | Press Release | $0.9160 $1.32 | ▲ +43.56% | ▲ +40.83% | $1.31 (+43.01%) |
May 19, 2026 23w ago | Press Release | $0.8060 $1.26 | ▲ +56.33% | ▲ +50.04% | $1.31 (+62.53%) |
May 15, 2026 23w ago | 10-K/A | $0.7830 $1.12 | ▲ +43.04% | ▲ +38.19% | $1.31 (+67.31%) |
May 14, 2026 23w ago | 8-K | $0.8200 $1.15 | ▲ +40.24% | ▲ +35.73% | $1.31 (+59.76%) |
Apr 29, 2026 25w ago | Press Release | $0.8310 $0.8653 | ▲ +4.13% | ▲ +0.02% | $1.31 (+57.64%) |
Apr 28, 2026 26w ago | EFFECT | $0.8400 $0.8545 | ▲ +1.73% | ▼ −2.26% | $1.31 (+55.95%) |
Apr 16, 2026 27w ago | S-3 | $1.00 $0.8500 | ▼ −15.00% | ▼ −21.14% | $1.31 (+31.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers